Isodiol International Inc ISOLF

RE:RE:RE:SHAKE OUR HEADS

[iplaygolf]

Longterm CBD pharma will be bigger than rec weed. IMO. Give people time to learn. Most investors in the LPs may never smoke in their life and are investing.  You can bet they will use a CBD product in years once they know the benefits and stop comparing it to getting high from marijuana and THC. Let’s hope Isol can become top 3 of the cbd players.  WEED was this price two years ago.  If you’re impatient or want in on the gains elsewhere feel free (I relocated some recently and not upset about it) but I’m definitely holding a long position on this potential powerhouse. 










quote=TheJudger]

InForTheLongHau wrote: Vida has like 1/4 the float we do keep in mind so less volume needed to get it moving.

this is still being held down for whatever reason none of us are sure. 

It it is an opportunity cost yes, but It’s a safe hedge against the overvalued LPs and Rex market IMO.

Overvalued?!  If anything is overvalued it’s ISOL.  Their projected revenue for 2018 is approx $60 million with a profit of approx $5 million - expect further declines with Isodiol.

The LP’s on average are going to produce on average 40,000kg of Marijuana per year, which equals to $350 million/year.  Average profit margins are approx $5/gram which equals to $200 million per year.  The average LP will net $200 million profit per year versus Isodiol’s measly $5 million per year.
And that’s just the intermediate LP numbers!  The big guys like WEED will be generating around $700 million per year.  Also many of the LP’s are building million plus square feet growing facilities that will be completed by 2019.  These LP’s will be generating over a billion in revenue come 2020.  Saying the LP’s are overvalued using their current earnings and comparing them to ISOL’s is very near sighted and a great way to miss out on serious gains over the next few months.  Fortunes are going to be made, but not for those that stick with this laggard play.  


[/quote]